These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Crossline levels in serum and erythrocyte membrane proteins from patients with diabetic nephropathy. Aoki S; Hasegawa G; Shigeta H; Obayashi H; Fujii M; Kimura F; Moriwaki A; Nakamura N; Ienaga K; Nakamura K; Kondo M Diabetes Res Clin Pract; 2000 May; 48(2):119-25. PubMed ID: 10802149 [TBL] [Abstract][Full Text] [Related]
23. Thermal properties and fluidity of human erythrocyte membranes in diabetes mellitus. Przybylska M; Bryszewska M; Chapman IV Int J Radiat Biol; 1993 Mar; 63(3):419-24. PubMed ID: 8095294 [TBL] [Abstract][Full Text] [Related]
24. Hyperglycaemia alters the physico-chemical properties of proteins in erythrocyte membranes of diabetic patients. Watala C Int J Biochem; 1992 Nov; 24(11):1755-61. PubMed ID: 1333422 [TBL] [Abstract][Full Text] [Related]
25. [Non-enzymatic protein glycosylation and its role in the clinical pathophysiology of diabetes mellitus]. Czech A Pol Tyg Lek; 1986 Mar; 41(11):343-7. PubMed ID: 3520516 [No Abstract] [Full Text] [Related]
26. [Glycosylated proteins and the rheological properties of the erythrocytes in carbohydrate metabolic disorders]. Galenok VA; Khanykina IV Ter Arkh; 1991; 63(12):113-6. PubMed ID: 1803588 [TBL] [Abstract][Full Text] [Related]
27. [Effect of vitamin C and E on nonenzymatic glycation and physico- chemical properties of isolated erythrocyte membranes in diabetic patients]. Waczulikova I; Krahulec B; Sikurova L; Carsky J; Orszaghova Z; Durackova Z Bratisl Lek Listy; 2000; 101(3):152-6. PubMed ID: 10870259 [TBL] [Abstract][Full Text] [Related]
28. Erythrocyte membrane fluidity in type 1 diabetes mellitus. Hill MA; Court JM Pathology; 1983 Oct; 15(4):449-51. PubMed ID: 6674874 [TBL] [Abstract][Full Text] [Related]
29. Selective determination of non-enzymatic glycosylated serum albumin as a medium term index of diabetic control. Wörner W; Pfleiderer S; Rietbrock N Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):218-22. PubMed ID: 8314651 [TBL] [Abstract][Full Text] [Related]
30. Fluidity gradient of erythrocyte membranes in diabetics: the effect of resorcylidene aminoguanidine. Waczulíková I; Sikurová L; Cársky J Bioelectrochemistry; 2002 Jan; 55(1-2):53-5. PubMed ID: 11786339 [TBL] [Abstract][Full Text] [Related]
31. The phospholipid composition of erythrocyte ghosts and plasma lipoproteins in diabetes type 1 in children. Watała C; Jóźwiak Z Clin Chim Acta; 1990 May; 188(3):211-9. PubMed ID: 2387073 [TBL] [Abstract][Full Text] [Related]
32. [Dynamic changes in the blood glucose, glycosylated hemoglobin and glycosylated serum protein values in patients with diabetes mellitus]. Kalpazanova N; Dosheva I; Klechkova L Vutr Boles; 1987; 26(6):107-10. PubMed ID: 3439144 [TBL] [Abstract][Full Text] [Related]
33. The nonenzymatic glycosylation of proteins. Bailey AJ Horm Metab Res Suppl; 1981; 11():90-4. PubMed ID: 6947955 [No Abstract] [Full Text] [Related]
34. [Glycosylation of hemoglobin and plasma proteins in petrochemical plant workers]. Unrug A; Tomaszewski L Med Pr; 1985; 36(6):368-76. PubMed ID: 3835430 [TBL] [Abstract][Full Text] [Related]
35. Liver and kidney tissue membranes as tissue markers for nonenzymatic glycosylation. Cefalu WT; Wang ZQ; Bell-Farrow A; Ralapati S Diabetes; 1991 Jul; 40(7):902-7. PubMed ID: 2060726 [TBL] [Abstract][Full Text] [Related]
36. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Candiloros H; Muller S; Zeghari N; Donner M; Drouin P; Ziegler O Diabetes Care; 1995 Apr; 18(4):549-51. PubMed ID: 7497868 [TBL] [Abstract][Full Text] [Related]
37. Erythrocyte membrane microviscosity in diabetes. Otsuji S; Baba Y; Kamada T Horm Metab Res Suppl; 1981; 11():97-102. PubMed ID: 6274779 [TBL] [Abstract][Full Text] [Related]
38. Membrane fluidity is related to the extent of glycation of proteins, but not to alterations in the cholesterol to phospholipid molar ratio in isolated platelet membranes from diabetic and control subjects. Winocour PD; Watala C; Kinglough-Rathbone RL Thromb Haemost; 1992 May; 67(5):567-71. PubMed ID: 1519216 [TBL] [Abstract][Full Text] [Related]
39. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets. Watala C; Gwoździński K; Pluskota E; Pietrucha T; Walkowiak B; Trojanowski Z; Cierniewski CS Thromb Haemost; 1996 Jan; 75(1):147-53. PubMed ID: 8713794 [TBL] [Abstract][Full Text] [Related]
40. Fluidity and fatty acid components of erythrocyte membranes in diabetic retinopathy. Yang G; Qiu H; Wang S; Deng H; Zhang S; Li L Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):407-12. PubMed ID: 10862451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]